Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05224050Phase 2Completed
Phase 2, open-label, single-arm trial, sponsored by Rutgers University. Primary endpoints: Intervention Feasibility: Participant Attendance at 6 weeks, Intervention Feasibility: Participant Practice Adherence at 6 weeks and 5 more. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05224050.